- Home
- EPRX vs RBKB Comparison
EPRX vs RBKB Comparison
Compare EPRX & RBKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPRX
- RBKB
- Stock Information
- Founded
- EPRX 2011
- RBKB 1860
- Country
- EPRX Canada
- RBKB United States
- Employees
- EPRX N/A
- RBKB N/A
- Industry
- EPRX
- RBKB Banks
- Sector
- EPRX
- RBKB Finance
- Exchange
- EPRX NYSE
- RBKB Nasdaq
- Market Cap
- EPRX 130.0M
- RBKB 111.3M
- IPO Year
- EPRX N/A
- RBKB 2019
- Fundamental
- Price
- EPRX $3.28
- RBKB $10.40
- Analyst Decision
- EPRX Strong Buy
- RBKB
- Analyst Count
- EPRX 1
- RBKB 0
- Target Price
- EPRX $9.00
- RBKB N/A
- AVG Volume (30 Days)
- EPRX 11.9K
- RBKB 4.9K
- Earning Date
- EPRX 05-07-2025
- RBKB 04-24-2025
- Dividend Yield
- EPRX N/A
- RBKB N/A
- EPS Growth
- EPRX N/A
- RBKB N/A
- EPS
- EPRX N/A
- RBKB N/A
- Revenue
- EPRX N/A
- RBKB $25,911,000.00
- Revenue This Year
- EPRX N/A
- RBKB N/A
- Revenue Next Year
- EPRX N/A
- RBKB N/A
- P/E Ratio
- EPRX N/A
- RBKB N/A
- Revenue Growth
- EPRX N/A
- RBKB N/A
- 52 Week Low
- EPRX $2.20
- RBKB $7.30
- 52 Week High
- EPRX $4.48
- RBKB $10.50
- Technical
- Relative Strength Index (RSI)
- EPRX N/A
- RBKB 56.45
- Support Level
- EPRX N/A
- RBKB $9.72
- Resistance Level
- EPRX N/A
- RBKB $10.45
- Average True Range (ATR)
- EPRX 0.00
- RBKB 0.16
- MACD
- EPRX 0.00
- RBKB -0.04
- Stochastic Oscillator
- EPRX 0.00
- RBKB 87.26
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.
About RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one- to four-family residential real estate loans, and to purchase investment securities.